Add BrightSurf on Google Email

Stanford Medicine


Drug limits dangerous reactions to allergy-triggering foods, Stanford Medicine-led study of kids finds

A Stanford Medicine-led study found that the drug omalizumab can prevent dangerous allergic responses in children with food allergies. The research showed that two-thirds of participants who received the drug safely ate small amounts of their allergy-triggering foods, including peanuts and other common allergens.

SourceStanford Medicine·JournalNew England Journal of Medicine·TypeRandomized controlled/clinical trial·DateFeb 25, 2024

Metastatic breast cancer treatments have aided decline in deaths, Stanford Medicine-led study finds

A Stanford Medicine-led study found that advances in treating metastatic breast cancer are responsible for nearly one-third of the decrease in annual deaths from breast cancer between 1975 and 2019. This decline is attributed to improved treatments, which have enabled women with metastatic disease to live longer than ever.

SourceStanford Medicine·JournalJournal of the American Medical Association·TypeData/statistical analysis·DateJan 17, 2024

Scientists use high-tech brain stimulation to make people more hypnotizable

Researchers found that less than two minutes of electrical stimulation targeting a precise area of the brain could increase participants' hypnotizability for about one hour. Highly hypnotizable individuals have stronger functional connectivity between the left dorsolateral prefrontal cortex and dorsal anterior cingulate cortex.,

SourceStanford Medicine·JournalNature Mental Health·TypeRandomized controlled/clinical trial·DateJan 4, 2024

Lung cancer screening guidelines perpetuate racial disparities, Stanford-led study finds

A recent study led by Stanford Medicine researchers found that national lung cancer screening guidelines are less effective for African Americans than whites. An alternative risk-based method showed better results in eliminating disparities among races. The disparities persist despite guideline revisions implemented in 2021.

SourceStanford Medicine·JournalJAMA Oncology·TypeData/statistical analysis·DateOct 27, 2023

Easy diet changes can lower carbon footprint, according to Stanford Medicine-led study

Researchers identified simple food swaps that can make a big difference in an individual's carbon footprint without drastic dietary overhaul. The suggested changes include replacing beef with chicken or plant-based milk, which could reduce the nation's food-related carbon footprint by more than 35% and improve overall dietary quality.

SourceStanford Medicine·JournalNature Food·TypeData/statistical analysis·DateOct 27, 2023

Ketamine’s effect on depression may hinge on hope

A study at Stanford Medicine found that patients who believed they had received ketamine experienced significant improvements in depression symptoms, even if they hadn't. The researchers suggest that positive expectations and hope may play a key role in ketamine's effectiveness.

SourceStanford Medicine·JournalNature Mental Health·TypeRandomized controlled/clinical trial·DateOct 19, 2023

Virtual reality helps people with hoarding disorder practice decluttering

A pilot study suggests that virtual reality therapy can help individuals with hoarding disorder practice decluttering by rehearsing organizational and decision-making skills in a simulated environment. Seven of nine participants showed significant improvements in self-reported hoarding symptoms, with an average decrease of 25%, and eig...

SourceStanford Medicine·JournalJournal of Psychiatric Research·TypeObservational study·DateOct 16, 2023

Research findings could explain why young kids rarely get very sick from COVID-19

Researchers discovered that young children's immune systems produce fewer and more stable antibodies against SARS-CoV-2, which may explain why they rarely develop severe cases of the virus. This unique response is characterized by narrow-spectrum antibodies effective against the original variant but less protective against other variants.

SourceStanford Medicine·JournalCell·TypeObservational study·DateOct 12, 2023

Wearable device data reveals that reduced sleep and activity in pregnancy is linked to premature birth risk

A study using wearable device data found that reduced sleep and physical activity during pregnancy are linked to an increased risk of preterm birth. The research, led by Stanford Medicine, collected data from over 1,000 women throughout pregnancy and identified patterns that can help prevent early deliveries.

SourceStanford Medicine·Journalnpj Digital Medicine·TypeExperimental study·DateSep 28, 2023

Stanford Medicine researchers map morphing placenta

The placenta forms an unusual organ that requires unique cooperation between genetically mismatched maternal and fetal cells. Researchers have mapped the intricate dance between trophoblasts and the mother's immune system, shedding light on how to develop new treatments for pregnancy complications like preeclampsia and miscarriages.

SourceStanford Medicine·JournalNature·DateJul 19, 2023

Satisfaction with online dating app depends on what you’re looking for

A new study by Stanford Medicine researchers found that many Tinder users are not swiping for dates, but rather for social connectedness, entertainment, or to cope with negative emotions. The study suggests that online dating is an ineffective coping mechanism for mental health challenges and recommends addressing underlying issues ins...

SourceStanford Medicine·JournalCyberpsychology Behavior and Social Networking·DateJul 11, 2023

Cancer’s origin story features predictable plot line, Stanford Medicine researchers find

Researchers at Stanford Medicine found that cancer cells accumulate a series of specific genetic changes in a predictable and sequential way, years before they are identifiable as pre-malignancies. These changes affect pathways controlling cell division, structure, and internal messaging, leaving the cells poised to go bad long before ...

SourceStanford Medicine·JournalNature·TypeObservational study·DateJul 7, 2023

Stanford Medicine-led research identifies a subtype of depression

Researchers have identified a subtype of depression, labeled the cognitive biotype, which accounts for 27% of depressed patients. This group has difficulty with planning, self-control, and focus, and shows reduced activity in brain regions responsible for these tasks. Targeting cognitive dysfunctions with less commonly used antidepress...

SourceStanford Medicine·JournalJAMA Network Open·TypeRandomized controlled/clinical trial·DateJun 23, 2023

Restoring the blood-brain barrier?

Researchers developed a new therapeutic molecule that activates WNT signaling to restore the blood-brain barrier's normal function. The treatment showed promise in treating conditions such as multiple sclerosis and ischemic stroke by reducing the severity of strokes and improving survival rates.

SourceStanford Medicine·JournalNature Communications·DateJun 20, 2023

Researchers treat depression by reversing brain signals traveling the wrong way

Researchers at Stanford Medicine have discovered that transcranial magnetic stimulation (TMS) treats depression by reversing abnormal brain signals. The treatment, which involves powerful magnetic pulses applied to the scalp, changes the flow of neural activity in the brain. By analyzing fMRI data, the team identified a key connection ...

SourceStanford Medicine·JournalProceedings of the National Academy of Sciences·DateMay 23, 2023

Stanford Medicine study shows differences between brains of girls, boys with autism

A new Stanford University School of Medicine study has identified unique differences in the brains of girls and boys with autism, which may help explain why symptoms differ between the sexes. The research used AI techniques to analyze hundreds of brain scans, revealing distinct patterns that were not found in typically developing boys ...

SourceStanford Medicine·JournalThe British Journal of Psychiatry·DateFeb 17, 2022

Stanford-led study: Antibodies in blood soon after COVID-19 onset may predict severity

A Stanford-led study found that blood antibodies in patients shortly after COVID-19 onset may indicate who is most likely to develop severe symptoms. The researchers discovered differences in antibody shapes and sugar chains between those with mild and severe symptoms, which could lead to a test to focus attention on those at risk.

SourceStanford Medicine·JournalScience Translational Medicine·DateJan 18, 2022